InMode Ltd. (NASDAQ:INMD) Stock Holdings Lifted by Federated Hermes Inc.

Federated Hermes Inc. lifted its holdings in InMode Ltd. (NASDAQ:INMD) by 5,512.7% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 582,434 shares of the healthcare company’s stock after buying an additional 572,057 shares during the quarter. Federated Hermes Inc. owned approximately 0.70% of InMode worth $12,953,000 as of its most recent filing with the SEC.

Other large investors also recently modified their holdings of the company. Exchange Traded Concepts LLC bought a new position in shares of InMode in the 3rd quarter worth about $27,000. Carmel Capital Partners LLC acquired a new stake in shares of InMode in the 3rd quarter worth about $36,000. Newbridge Financial Services Group Inc. acquired a new stake in shares of InMode in the 3rd quarter worth about $40,000. Sunbelt Securities Inc. acquired a new stake in shares of InMode in the 3rd quarter worth about $47,000. Finally, NBC Securities Inc. acquired a new stake in shares of InMode in the 3rd quarter worth about $79,000. 68.04% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A number of research firms recently weighed in on INMD. Needham & Company LLC reaffirmed a “hold” rating on shares of InMode in a report on Tuesday, April 9th. UBS Group increased their price objective on shares of InMode from $24.00 to $26.00 and gave the stock a “neutral” rating in a report on Wednesday, February 14th. Finally, Barclays lowered their target price on shares of InMode from $34.00 to $33.00 and set an “overweight” rating on the stock in a research note on Friday, April 12th. Four research analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $32.80.

InMode Trading Up 1.3 %

InMode stock opened at $17.37 on Wednesday. The stock has a market cap of $1.46 billion, a price-to-earnings ratio of 7.55 and a beta of 2.16. The company’s 50-day moving average price is $20.68 and its two-hundred day moving average price is $21.72. InMode Ltd. has a 52 week low of $16.96 and a 52 week high of $48.25.

InMode (NASDAQ:INMD) last released its earnings results on Tuesday, February 13th. The healthcare company reported $0.71 EPS for the quarter, beating the consensus estimate of $0.66 by $0.05. The firm had revenue of $126.80 million for the quarter, compared to analysts’ expectations of $124.77 million. InMode had a net margin of 40.22% and a return on equity of 29.80%. InMode’s quarterly revenue was down 5.1% on a year-over-year basis. During the same quarter last year, the company earned $0.69 EPS. Research analysts expect that InMode Ltd. will post 2.04 earnings per share for the current fiscal year.

InMode Company Profile

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures.